ENTX · Entera Bio Ltd
United States · RS rating 78 · As of 2026-10-14
| Price | 2.50 USD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 19 / 92 / 34 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 34 / 55 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -100.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +36.2% |
| Market cap (USD) | $63.7M |